Thorsten Stiewe
Impact in
- Oncology top 1%
- Cancer-related Molecular Pathways
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Epigenetics and DNA Methylation 29
- RNA modifications and cancer 22
- Genomics and Chromatin Dynamics 13
- RNA Research and Splicing 10
- Oncology 63
- Cancer-related Molecular Pathways 45
- Co-authors
- Brigitte M. Pützer (12 shared papers)Andrea Nist (80 shared papers)Florian Finkernagel (30 shared papers)Marco Mernberger (28 shared papers)Till Adhikary (12 shared papers)Helmut Esche (6 shared papers)Tali E. Haran (1 shared paper)Rolf Müller (17 shared papers)
- Journals
- Nucleic Acids Research (11 papers)Cancers (10 papers)Nature Communications (6 papers)Cell Death and Disease (5 papers)PLoS ONE (4 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Thorsten Stiewe
156 papers receiving 6.1k citations
Thorsten Stiewe's Hit Papers
Peers
Comparison fields: 5 of 149
- Oncology 2.3k
- Cancer Research 1.0k
- Biotechnology 507
- Molecular Biology 3.8k
- Immunology 924
Countries citing papers authored by Thorsten Stiewe
This map shows the geographic impact of Thorsten Stiewe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thorsten Stiewe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thorsten Stiewe more than expected).
Fields of papers citing papers by Thorsten Stiewe
This network shows the impact of papers produced by Thorsten Stiewe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thorsten Stiewe. The network helps show where Thorsten Stiewe may publish in the future.
Co-authors
The 25 scholars most cited alongside Thorsten Stiewe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 159 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes Hit paper breakdown → | 2019 | 387 |
| 2 | 2000 | 282 | |
| 3 | 2020 | 268 | |
| 4 | 2007 | 229 | |
| 5 | 2019 | 195 | |
| 6 | 2013 | 187 | |
| 7 | 2002 | 151 | |
| 8 | 2011 | 149 | |
| 9 | Transactivation-deficient DeltaTA-p73 acts as an oncogene. | 2002 | 147 |
| 10 | 2020 | 139 | |
| 11 | 2002 | 130 | |
| 12 | 2020 | 120 | |
| 13 | 2022 | 112 | |
| 14 | 2018 | 100 | |
| 15 | 2015 | 96 | |
| 16 | 2006 | 91 | |
| 17 | 2015 | 91 | |
| 18 | 2016 | 87 | |
| 19 | 2010 | 87 | |
| 20 | 2018 | 87 |
About Thorsten Stiewe
Thorsten Stiewe is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Genetics, having authored 159 papers that have together received 6.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (45 papers), Epigenetics and DNA Methylation (29 papers), RNA modifications and cancer (22 papers), Cancer Research and Treatments (13 papers), Genomics and Chromatin Dynamics (13 papers), Immune cells in cancer (13 papers), RNA Research and Splicing (10 papers) and Virus-based gene therapy research (9 papers). The work is most often cited by research in Oncology (2.3k citations), Cancer Research (1.0k citations), Biotechnology (507 citations), Molecular Biology (3.8k citations) and Immunology (924 citations). Thorsten Stiewe has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Brigitte M. Pützer, Andrea Nist, Florian Finkernagel, Marco Mernberger, Till Adhikary, Helmut Esche, Tali E. Haran, Rolf Müller, Silke Reinartz and Anne Catherine Bretz. Their work appears in journals such as Nucleic Acids Research, Cancers, Nature Communications, Cell Death and Disease and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.